CoChat

Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate: A Randomized, Double-Blind, Placebo-Controlled Trial

The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Adults and children in the United States get two to six colds per year. Evidence that zinc is effective therapy for colds is inconsistent. OBJECTIVE: To test the efficacy of zinc acetate lozenges in reducing the duration of symptoms of the common cold. DESIGN: Randomized, double-blind, placebo-controlled trial. SETTING: Detroit Medical Center, Detroit, Michigan. PATIENTS: 50 ambulatory volunteers recruited within 24 hours of developing symptoms of the common cold. INTERVENTION: Participants took one lozenge containing 12.8 mg of zinc acetate or placebo every 2 to 3 hours while awake as long as they had cold symptoms. MEASUREMENTS: Subjective symptom scores for sore throat, nasal discharge, nasal congestion, sneezing, cough, scratchy throat, hoarseness, muscle ache, fever, and headache were recorded daily for 12 days. Plasma zinc and proinflammatory cytokine levels were measured on day 1 and after participants were well. RESULTS: Forty-eight participants completed the study (25 in the zinc group and 23 in the placebo group). Compared with the placebo group, the zinc group had shorter mean overall duration of cold symptoms (4.5 vs. 8.1 days), cough (3.1 [95% CI, 2.1 to 4.1] vs. 6.3 [CI, 4.9 to 7.7] days), and nasal discharge (4.1 [CI, 3.3 to 4.9] vs. 5.8 [CI, 4.3 to 7.3] days) and decreased total severity scores for all symptoms (P < 0.002, test for treatment x time interaction). Mean changes in soluble interleukin-1 receptor antagonist level differed nonsignificantly between the zinc group and the placebo group (difference between changes, -89.4 pg/mL [CI, -243.6 to -64.8 pg/mL]). CONCLUSION: Administration of zinc lozenges was associated with reduced duration and severity of cold symptoms, especially cough. Improvement in clinical symptoms with zinc treatment may be related to a decrease in proinflammatory cytokine levels; however, in this study, the observed differences between changes in cytokine levels in zinc and placebo recipients were not significant.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-133-4-200008150-00006

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Research works printed but not linked: 4

  1. Weismann E, 1990, Dan Med Bull, 37, 279
  2. Koch AE, 1995, J Invest Med, 43, 28
  3. Pitkaranta A, 1998, Infections in Medicine, 15, 50
  4. Beck FW, 1997, Am J Physiol, 272, E1002

Cited by

See all 240

Metadata

Authors
Prasad, A. S., Fitzgerald, J. T., Bao, B., Beck, F. W. J., & Chandrasekar, P. H.
Affiliations
Wayne State University (US)
Venue
Annals of Internal Medicine
Published
2000-08-15
Volume
133
Issue
4
Pages
245-252
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2093316627
Cited by
228
References
41
Citations by year
2026: 2 · 2025: 6 · 2024: 4 · 2023: 3 · 2022: 13 · 2021: 9 · 2020: 19 · 2019: 8 · 2018: 2 · 2017: 4 · 2016: 6 · 2015: 11 · 2014: 10 · 2013: 3 · 2012: 3
FWCI
32.13
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Herbal Medicine Research Studies
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pediatric health and respiratory diseases
Keywords
common cold, zinc acetate, zinc lozenges, symptom duration, symptom severity, cough, rhinorrhea, inflammatory cytokines, interleukin-1 receptor antagonist, plasma zinc, zinc supplementation
MeSH terms
Adult, Common Cold, Cough, Double-Blind Method, Female, Humans, Male, Nasal Mucosa, Placebos, Research Design, Cytokines, Treatment Outcome, Receptors, Interleukin-1, Receptors, Tumor Necrosis Factor, Zinc Acetate, Neopterin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate: A Randomized, Double-Blind, Placebo-Controlled Trial. https://app.cochat.ai/papers/10.7326/0003-4819-133-4-200008150-00006
The paper
Prasad, A. S., Fitzgerald, J. T., Bao, B., Beck, F. W. J., & Chandrasekar, P. H. (2000). Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate: A Randomized, Double-Blind, Placebo-Controlled Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-133-4-200008150-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.